1. Home
  2. ERII vs AQST Comparison

ERII vs AQST Comparison

Compare ERII & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Recovery Inc.

ERII

Energy Recovery Inc.

HOLD

Current Price

$8.11

Market Cap

595.9M

Sector

Technology

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.03

Market Cap

504.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERII
AQST
Founded
1992
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
595.9M
504.0M
IPO Year
2008
2007

Fundamental Metrics

Financial Performance
Metric
ERII
AQST
Price
$8.11
$4.03
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$17.07
$9.00
AVG Volume (30 Days)
1.3M
1.7M
Earning Date
05-06-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
5.00
N/A
EPS
N/A
N/A
Revenue
$134,987,000.00
$67,430,000.00
Revenue This Year
N/A
$10.08
Revenue Next Year
$20.55
$49.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.77
52 Week Low
$8.14
$2.68
52 Week High
$18.31
$7.55

Technical Indicators

Market Signals
Indicator
ERII
AQST
Relative Strength Index (RSI) 33.47 44.22
Support Level N/A $4.00
Resistance Level $11.58 $4.38
Average True Range (ATR) 0.42 0.20
MACD -0.02 -0.03
Stochastic Oscillator 1.61 6.07

Price Performance

Historical Comparison
ERII
AQST

About ERII Energy Recovery Inc.

Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: